Search results
What are the new COVID FLiRT variants, and are they in Wisconsin?
Gannett via AOL· 7 days agoSymptoms may appear two to 14 days after exposure. Latest COVID guidance from the CDC In March 2024,...
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
Motley Fool via Yahoo Finance· 20 hours agoPfizer Pfizer (NYSE: PFE) is one of the world's leading pharmaceutical companies, but it's fallen...
Platinum price today: Platinum is up 3.05% year to date
USA Today· 19 hours agoThe chart below shows how the spot price of platinum is trending over the year. The price of XPT/USD...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel COVID-19...
Earnings call: DiaMedica Therapeutics discusses Q1 progress and challenges By Investing.com
Investing.com· 2 days agoThe company is focused on ramping up site activation and participant enrollment for its ReMEDy2...
California’s budget deficit has grown. Here’s how Gov. Newsom is responding
Los Angeles Times· 20 hours agoGov. Gavin Newsom released his revised $288-billion budget proposal last week, which included a...
Q1 2024 Imunon Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 24 hours agoAnd as we reported this morning, enrollment has begun as promised in our Phase 1 vaccine study of immunized 101. A proof-of-concept trial to evaluate the immunization of patients against < ...
Chief medical officer denies straying into political issues during pandemic
Press Association News via AOL· 5 days agoA full transcript of today’s hearing will be available on the website shortly with an accessible...
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
NewMediaWire via Yahoo Finance· 14 hours agoPresented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven...
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 6 days agoBut the science of DNA-based drugs was on the experimental fringe of the biopharma landscape. Not...